Posts Categorized: MS News

Source MS Trust: The development of new drugs is a long and difficult process. Fewer than one or two compounds in 10,000 tested actually make it through to being licensed treatments with many being rejected on safety, efficacy or quality grounds. On average it will take 10-15 years for a new compound to get from… Read more »

Source Independent: Ministers have spent almost £40m in an “appalling” attempt to stop sick and disabled people receiving the financial help they are entitled to, The Independent can reveal. Freedom of Information requests have exposed how taxpayers’ money has been spent on futile legal battles to prevent vulnerable people receiving help. The hit to the public purse… Read more »

Source Multiple Sclerosis News Today: A substance that the pancreas secretes can promote the regeneration of the protective nerve-cell coating that is damaged in multiple sclerosis, a mouse study shows. The substance is fibroblast growth factor 21, or FGF21. It promotes remyelination, the renewal of the myelin sheath protecting the central nervous system, according to the… Read more »

Source  Caroline Wyatt, The Telegraph: I lay face down on a pedestrian crossing, knees bleeding where they’d hit the road.  I couldn’t get back on my feet, even as the lights changed. It was May 2016 and I’d been on my way to meet friends when  I fell without warning. The next day I woke too… Read more »

Source MS Trust: The European Commission (EC) has granted marketing authorization for cladribine (Mavenclad)for the treatment of adults with highly active relapsing multiple sclerosis. This follows a recommendation from the European Medicines Agency in June that a licence should be granted. Cladribine will now need to be appraised by NICE and the SMC to determine NHS availability in the UK. NICE has… Read more »

Source Shift-MS: This short guide is a resource to help people with multiple sclerosis (MS) understand how they can keep their brains as healthy as possible and request the highest possible standard of care from healthcare professionals. It explains how people with MS can put into practice the recommendations from the report Brain health: time… Read more »

A third of MS sufferers who previously received the highest rate of Disability Living Allowance have had their payments downgraded since 2013. Thousands of people living with multiple sclerosis (MS) have lost millions of pounds in benefits since disability benefits system was changed four years ago, new figures show. More than £6m a year has… Read more »

In this video from Patients Like Me, John shares that although he’s suffering from the autoimmune disease multiple sclerosis (MS), he’s definitely much more than the disease. MORE: How doctors treat spasticity in MS John explains that when the MS symptoms he was experiencing began to affect his everyday life, he had to take action. A… Read more »

This video from the Center for Diagnostic Imaging explains how magnetic resonance imaging (MRI) can help in diagnosing multiple sclerosis (MS) and how far this technology has come in a relatively short time. MRIs can also track the progression of the disease. MORE: 10 things to know about multiple sclerosis in children Dr. Steven Pollei, a CDI neuroradiologist,… Read more »

The multiple The multiple sclerosis community has been waiting with bated breath for the approval of the drug Ocrevus (ocrelizumab), which will be used to treat patients who have relapsing MS and primary progressive MS. The FDA’s decision of final approval arrived on March 28, which coincides with Multiple Sclerosis Awareness Week. In preparation for the announcement, we’ve put… Read more »